GSTz1 genotype and cognitive ability

Psychiatric Genetics

Volumn 18, Issue 4, 2008, Pages 211-212

  Starr, John M ^a,d   Fox, Helen ^c   Harris, Sarah E ^b   Deary, Ian J ^b   Whalley, Lawrence J ^c  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d Royal Victoria Hospital Edinburgh   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; GLUTATHIONE TRANSFERASE; GSTZ1 PROTEIN, HUMAN;

AGED; COGNITION; COGNITIVE DEFECT; DOPAMINE METABOLISM; GENE; GENETIC VARIABILITY; GENOTYPE; GSTZ1 GENE; HOMOZYGOTE; HUMAN; INTELLIGENCE QUOTIENT; LETTER; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VERBAL MEMORY; WECHSLER INTELLIGENCE SCALE; GENETICS; MIDDLE AGED;

AGED; COGNITION; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 50349100411     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e328304dea8     Document Type: Letter

References (4)

1. Fang YY, Kashkarov U, Anders MW, Board PG (2006). Polymorphisms in the human glutathione transferase zeta promoter. Pharmacogenet Genomics 16:307-313.
2. Savitz J, Solms M, Ramesar R (2006). The molecular genetics of cognition: dopamine, COMT and BDNF. Genes, Brain and Behavior 5:311-328.
3. Starr JM, Fox H, Harris SE, Deary IJ, Whalley LJ (2007). COMT genotype and cognitive ability: a longitudinal aging study. NQeuroscience Letters 421:57-61.
4. Weingarten P, Zhou Q-Y (2001). Protection of intracellular dopamine cytotoxicity by dopamine disposition and metabolism factors. J Neurochem 77:776-785.